Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has cancelled its plans for an initial public offering in the US, leading to the termination of lock-up agreements with its Joint Lead Managers, who have consequently ceased to be substantial holders in the company. This follows a previous announcement and the submission of the required notice to the ASX, marking a significant shift in the company’s financial strategy.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
